HeartStation Selects iBASIS eSIM for Remote Monitoring of AEDs to Ensure They Are Fully Powered and Operational in the Event of an Emergency

mJOULE Launches in the United Kingdom Reports Sciton

"Sciton is dedicated to worldwide support and growth. We continue to demonstrate our commitment to developing high quality devices and marketing efforts for our physician and medspa partners worldwide." says Lacee J. Naik, Vice President of Marketing and Public Relations.

FDA Issues Draft Guidance on Remanufacturing and Discussion Paper Seeking Feedback on Cybersecurity Servicing of Medical Devices

With this in mind, the FDA is issuing today's draft guidance to help clarify whether activities performed on medical devices are likely remanufacturing as well as a discussion paper on cybersecurity servicing of devices.

Irrimax Receives FDA Clearance for Irrisept

"This new clearance from the FDA further solidifies Irrisept as the market leader in wound irrigation," said Mark Alvarez, CEO of Irrimax.

Today iBASIS, a provider of communications solutions for operators and digital players worldwide, announced that HeartStation, a global manufacturer of Automated External Defibrillator (AED) cabinets and accessibility products, has selected iBASIS eSIM for remote monitoring of AEDs to ensure they are fully powered and operational in the event of an emergency.

iBASIS’ selection follows one of the fastest implementations of its IoT solution to date, with field trials completed in just five days in late December 2019 and solution installed as of January 2020.

As the U.S. National Safety Council reports, greater access to AEDs could save 40,000 lives each year in the U.S. alone, and access to fully powered AEDs by bystanders can increase the odds of survival up to 40% and higher.1 The iBASIS eSIM enables dynamic monitoring of AEDs via an eSIM card installed within the AED cabinet. A signal is regularly monitored during the AED self-test, with automatic alerts to dispatch a technician should the device not meet the necessary operation.

Over 50,000 HeartStation AED units will be globally, remotely monitored via the iBASIS eSIM. The iBASIS solution is differentiated in its ability to enable dynamic routing selection of communications carrier in the cloud to drive the most effective network connectivity to remotely monitor and manage devices worldwide.

“The iBASIS eSIM is the perfect solution to further enhance the effectiveness of critical public access defibrillation programs by enabling remote monitoring of AEDs,” says Keith Hochhalter, President, HeartStation. “This solution ensures that devices will be fully available in critical circumstances, and we are very proud to partner with a company that shares our commitment to delivering life-changing innovation and performance.”

“HeartStation has developed unsurpassed capabilities for enhancing access to lifesaving devices,” says Ajay CTO, iBASIS. “We are extremely pleased to partner with them to deliver the remote monitoring needed to ensure their devices are always powered. We are also very happy with the incredible speed with which the teams have implemented the iBASIS eSIM capability. Our work with HeartStation reflects our commitment to enabling companies around the world to rapidly achieve the highest performance in management and monitoring of their products globally.”


Reference

1 Source: US National Safety Council

spot_img

DON'T MISS

Hyperfine Adds Medtech Leader and Visionary Scott Huennekens as Executive Chairman

Mr. Huennekens’ public boards include Chairman of Acutus Medical (IPO August 2020); Chairman of Envista (IPO September 2019); and board member of Nuvasive. He also serves as a board member and past Chairman of the Medical Device Manufacturer’s Association (MDMA).

One Drop Reports Carrie Siragusa, CPA Appointed VP of Commercial Strategy, Biosensor

Formerly Head of Innovation and Diabetes Portfolio at Sanofi, Siragusa will be part of a team bringing a multi-analyte dermal sensor (biosensor) with continuous health sensing capabilities to market with a mission to provide broader access to continuous glucose monitoring.

Barbara Moorhouse Appointed as Medica Non-Executive Director

Barbara has extensive business and management experience in the private, public, and regulated sectors.

Subscribe to Medical Device News Magazine here.

Related Articles